抗栓治疗下腹腔镜腹股沟疝修补术的安全性
本研究基于Vizient临床数据库回顾性分析2017–2019年接受门诊择期原发性腹股沟疝修补的成人抗栓治疗患者,比较腹腔镜与开放手术的结局。结果显示非阿司匹林抗血小板或抗凝治疗是选择开放手术的独立预测因素,而腹腔镜修补与更短住院时间相关,30天并发症发生率与开放手术相似。
要点
- 抗栓治疗患者占腹股沟疝修补人群的15%。
- 非阿司匹林抗血小板或抗凝治疗者更倾向接受开放手术。
- 腹腔镜修补与开放手术的30天并发症发生率相似。
核心结论
- 在当前围术期管理模式下,腹腔镜腹股沟疝修补术在抗栓治疗患者中似乎是安全的。
研究设计与样本
- 回顾性队列研究,使用Vizient临床数据库,纳入2017–2019年接受门诊择期原发性腹股沟疝修补的成人抗栓治疗患者,共142,052例修补,其中21,441例(15%)患者接受抗栓治疗。
主要发现
- 非阿司匹林抗血小板治疗患者接受开放手术的OR=1.2(95%CI 1.1–1.4),抗凝治疗患者OR=1.4(95%CI 1.3–1.5)。
- 腹腔镜修补与住院时间>1天的较低发生率相关(OR=0.65;95%CI 0.5–0.9)。
- 两组30天术后血肿、输血、卒中、心肌梗死、深静脉血栓、肺栓塞、再入院和急诊就诊率相似。
关键数值与推荐
- 非阿司匹林抗血小板或抗凝治疗是选择开放修补的独立预测因素。
- 腹腔镜修补与开放修补的30天并发症发生率相似。
临床怎么用
- 对于接受抗栓治疗的患者,腹腔镜腹股沟疝修补术可考虑作为安全选项,但需注意非阿司匹林抗血小板或抗凝治疗者更可能被选择开放手术。
局限性
- 回顾性研究设计可能存在选择偏倚和混杂因素。
- 数据来源于行政数据库,可能存在编码不准确或缺失信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: There are a paucity of data regarding the safety of laparoscopic inguinal hernia repair in patients on antiplatelet and anticoagulant therapy (APT/ACT). We aim to compare the postoperative outcomes of laparoscopic (LIHR) vs. open repair of inguinal hernias (OIHR) in patients on APT/ACT. METHOD: We conducted a retrospective cohort study using the Vizient Clinical DataBase. We included adults receiving APT/ACT who underwent outpatient, elective, and primary inguinal hernia repair between 2017 and 2019. Subgroup analysis was performed on patients receiving aspirin, non-aspirin antiplatelet, and anticoagulant therapy. Mixed-effects logistic regression was used to assess both the effect of APT/ACT on the probability of receiving LIHR vs OIHR and their respective outcomes. RESULT: A total of 142,052 repairs were included, of which 21,441 (15%) were performed on patients receiving APT/ACT. Mean age was 69 years (± 10.5) and 93% were male. 19% of hernias were bilateral. 40% of operations were performed at teaching hospitals. On multivariable analysis, patients on non-aspirin antiplatelet or anticoagulant therapy were more likely to receive an open procedure (Odds Ratio (OR) = 1.2; 95% Confidence Intervals (CI) [1.1, 1.4] and OR = 1.4; CI [1.3, 1.5], respectively). LIHR was associated with a lower rate of length of stay > 1 day (OR = 0.65; CI [0.5, 0.9]). Rates of 30-day postoperative hematoma, transfusions, stroke, myocardial infarction, deep venous thrombosis, pulmonary embolism, readmission, and emergency department visits were similar between the two operative approaches. CONCLUSION: Patients on APT/ACT represent a substantial proportion of those undergoing inguinal hernia repair. Non-aspirin antiplatelet or anticoagulant therapy are independent predictors of choosing an open repair. Laparoscopic repair appears to be safe in patients receiving APT/ACT under current perioperative management patterns.
引用
- Balch JA, Neal D, Crippen C, et al. Safety of laparoscopic inguinal hernia repair in the setting of antithrombotic therapy. Surg Endosc. 2022. PMID: 35674797. doi:10.1007/s00464-022-09360-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。